NCT05520567 2026-03-04A Study of Gilteritinib, Venetoclax and Azacitidine as a Combined Treatment for People Newly Diagnosed With Acute Myeloid LeukemiaAstellas Pharma IncPhase 1/2 Active not recruiting70 enrolled
NCT04240002 2026-01-05A Study of Gilteritinib (ASP2215) Combined With Chemotherapy in Children, Adolescents and Young Adults With FMS-like Tyrosine Kinase 3 (FLT3)/Internal Tandem Duplication (ITD) Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)Astellas Pharma IncPhase 1/2 Terminated9 enrolled 21 charts